13.50
price down icon2.24%   -0.31
after-market アフターアワーズ: 13.56 0.06 +0.44%
loading
前日終値:
$13.81
開ける:
$13.71
24時間の取引高:
351.68K
Relative Volume:
1.34
時価総額:
$798.97M
収益:
-
当期純損益:
$-168.02M
株価収益率:
-2.9923
EPS:
-4.5116
ネットキャッシュフロー:
$-152.10M
1週間 パフォーマンス:
-0.95%
1か月 パフォーマンス:
-17.68%
6か月 パフォーマンス:
-37.53%
1年 パフォーマンス:
+58.64%
1日の値動き範囲:
Value
$13.00
$13.73
1週間の範囲:
Value
$13.00
$14.13
52週間の値動き範囲:
Value
$8.665
$26.18

Dbv Technologies Adr Stock (DBVT) Company Profile

Name
名前
Dbv Technologies Adr
Name
セクター
Healthcare (1079)
Name
電話
33(0)155427878
Name
住所
107 AVENUE DE LA REPUBLIQUE, CHATILLON
Name
職員
161
Name
次回の収益日
2026-07-16
Name
最新のSEC提出書
Name
DBVT's Discussions on Twitter

Compare DBVT vs VRTX, REGN, ARGX, RVMD, ONC

株式 価格 時価総額 収益 当期純利益 現金流量 EPS
DBVT icon
DBVT
Dbv Technologies Adr
13.50 822.64M 0 -168.02M -152.10M -4.5116
VRTX icon
VRTX
Vertex Pharmaceuticals Inc
477.10 121.57B 12.34B 4.34B 3.71B 16.87
REGN icon
REGN
Regeneron Pharmaceuticals Inc
762.63 69.95B 14.92B 4.42B 3.79B 41.04
ARGX icon
ARGX
Argen X Se Adr
853.82 55.61B 4.16B 1.29B 734.26M 19.58
RVMD icon
RVMD
Revolution Medicines Inc
187.53 39.98B 742.00K -1.37B -1.07B -7.0731
ONC icon
ONC
Beone Medicines Ltd Adr
316.01 33.81B 5.76B 514.49M 1.10B 4.4813

Dbv Technologies Adr Stock (DBVT) Upgrades & Downgrades

日付 アクション アナリスト 評価の変更
2025-12-15 開始されました Cantor Fitzgerald Overweight
2025-12-03 開始されました Guggenheim Buy
2025-05-29 再開されました Goldman Sell
2023-01-04 アップグレード Societe Generale Hold → Buy
2022-12-16 ダウングレード Goldman Neutral → Sell
2022-05-10 ダウングレード Goldman Buy → Neutral
2021-09-14 アップグレード Societe Generale Hold → Buy
2021-01-22 ダウングレード Societe Generale Hold → Sell
2020-11-02 アップグレード Societe Generale Sell → Hold
2020-08-06 ダウングレード Societe Generale Buy → Sell
2020-08-05 繰り返されました H.C. Wainwright Buy
2020-03-17 ダウングレード Stifel Buy → Hold
2020-01-09 アップグレード Stifel Hold → Buy
2019-12-16 開始されました Citigroup Buy
2019-09-05 再開されました Morgan Stanley Equal-Weight
2019-06-17 開始されました Goldman Buy
2018-12-20 ダウングレード Barclays Overweight → Equal Weight
2018-12-20 ダウングレード BofA/Merrill Buy → Underperform
2018-12-20 ダウングレード Jefferies Buy → Hold
2018-12-20 ダウングレード Stifel Buy → Hold
2017-10-31 アップグレード Societe Generale Sell → Hold
2017-10-24 ダウングレード Societe Generale Buy → Sell
2017-10-23 ダウングレード Morgan Stanley Overweight → Equal-Weight
2017-06-23 開始されました Deutsche Bank Buy
2017-03-16 アップグレード Societe Generale Hold → Buy
2016-09-26 開始されました JMP Securities Mkt Outperform
2015-12-03 開始されました Barclays Overweight
2015-10-23 開始されました BofA/Merrill Buy
すべてを表示

Dbv Technologies Adr (DBVT) 最新ニュース

pulisher
Jul 24, 2026

Europe’s US-Listed ADRs Edged Higher Late Friday Morning - Finimize

Jul 24, 2026
pulisher
Jul 22, 2026

DBV Technologies on Track for Lowest Close Since December 2025 -- Data Talk - Moomoo

Jul 22, 2026
pulisher
Jul 17, 2026

DBV Technologies Files At-The-Market (ATM) Prospectus for Up to $150 Million of Sales - markets.businessinsider.com

Jul 17, 2026
pulisher
Jul 17, 2026

symbol__ Stock Quote Price and Forecast - CNN

Jul 17, 2026
pulisher
Jul 17, 2026

DBV Technologies Plans Viaskin Peanut Launch Prep, If Approved - Stock Titan

Jul 17, 2026
pulisher
Jul 16, 2026

DBV Technologies Reports Second Quarter and Half-Year 2026 Financial Results and Business Update - markets.businessinsider.com

Jul 16, 2026
pulisher
Jul 16, 2026

DBV Technologies narrows Q2 loss, funds operations into Q3 2027 - scanx.trade

Jul 16, 2026
pulisher
Jul 16, 2026

DBV Technologies Announces the Filing of its 2026 Half-Year Report ― Conditions for Accessing or Consulting the Report - markets.businessinsider.com

Jul 16, 2026
pulisher
Jul 16, 2026

DBV Technologies (NASDAQ: DBVT) sees $174.9M cash and Q3 2027 runway - Stock Titan

Jul 16, 2026
pulisher
Jul 16, 2026

DBV Technologies Announces the Filing of its 2026 Half-Year - GlobeNewswire

Jul 16, 2026
pulisher
Jul 14, 2026

DBV Technologies to Report Second Quarter 2026 Financial Results and Business Update on July 16, 2026 - markets.businessinsider.com

Jul 14, 2026
pulisher
Jul 14, 2026

DBV Technologies' July 16 webcast will cover Q2 results - Stock Titan

Jul 14, 2026
pulisher
Jul 13, 2026

ETFs Investing in DBV Technologies SA Sponsored ADR Stocks - TradingView

Jul 13, 2026
pulisher
Jul 07, 2026

Europe’s US-Listed ADRs Slipped Late Tuesday Morning - Finimize

Jul 07, 2026
pulisher
Jul 06, 2026

Half-Year Report on the DBV Technologies Liquidity Contract with ODDO BHF - markets.businessinsider.com

Jul 06, 2026
pulisher
Jul 06, 2026

DBV Technologies S.A. - Via Ritzau

Jul 06, 2026
pulisher
Jul 06, 2026

DBV Technologies posts half-year liquidity contract figures - Stock Titan

Jul 06, 2026
pulisher
Jul 01, 2026

Wall Street Analysts Are Bullish on Top Healthcare Picks - The Globe and Mail

Jul 01, 2026
pulisher
Jun 29, 2026

DBV Technologies (NASDAQ: DBVT) targets Q3 2026 for VIASKIN Peanut BLA filing - Stock Titan

Jun 29, 2026
pulisher
Jun 29, 2026

DBV Technologies Provides BLA Submission Update for the VIASKIN® Peanut Patch in Children Aged 4 through 7 Years; Working Collaboratively with FDA to Optimize Review Process in Preparation for Filing - The Manila Times

Jun 29, 2026
pulisher
Jun 29, 2026

European ADRs Rose As Biopharma Names Led The Pack - Finimize

Jun 29, 2026
pulisher
Jun 27, 2026

A40WEX Forecast — Price Target — Prediction for 2027 - TradingView

Jun 27, 2026
pulisher
Jun 26, 2026

European ADRs Climb In Thursday U.S. Morning Session: ARGX, PHIA, CRTO In Focus - foreignpolicyjournal.com

Jun 26, 2026
pulisher
Jun 25, 2026

European ADRs Rose In US Trading Late Thursday Morning - Finimize

Jun 25, 2026
pulisher
Jun 25, 2026

DBV1 Forecast — Price Target — Prediction for 2027 - TradingView

Jun 25, 2026
pulisher
Jun 23, 2026

DBV Technologies Announces Inclusion in the Euronext Tech Leaders Index - markets.businessinsider.com

Jun 23, 2026
pulisher
Jun 17, 2026

DBV Technologies (ENXTPA:DBV) Advances Peanut Patch With New Phase 3 Data And Infant Trial - Yahoo Finance

Jun 17, 2026
pulisher
Jun 16, 2026

DBV Technologies (DBVT) soars 5.3%: Is further upside left in the stock? - MSN

Jun 16, 2026
pulisher
Jun 15, 2026

DBV Technologies (DBVT) Soars 5.3%: Is Further Upside Left in the Stock? - Yahoo Finance

Jun 15, 2026
pulisher
Jun 12, 2026

Analysts Offer Insights on Healthcare Companies: Enliven Therapeutics (ELVN) and Oncolytics Biotech (ONCY) - The Globe and Mail

Jun 12, 2026
pulisher
Jun 11, 2026

DBV Technologies Screens First Infant in THRIVE Peanut Patch Trial - HCP Live

Jun 11, 2026
pulisher
Jun 09, 2026

DBV Technologies Revises Participation in the Goldman Sachs 47th Annual Global Healthcare Conference - markets.businessinsider.com

Jun 09, 2026
pulisher
Jun 09, 2026

DBV Technologies to Present New Positive Data from VITESSE Study and Preview Recently Initiated THRIVE Study at the EAACI Congress 2026 - The Manila Times

Jun 09, 2026
pulisher
Jun 08, 2026

Peanut patch helps allergic kids with asthma and eczema in trial - Stock Titan

Jun 08, 2026
pulisher
Jun 05, 2026

DBV Technologies to Participate in the Goldman Sachs 47th Annual Global Healthcare Conference - markets.businessinsider.com

Jun 05, 2026
pulisher
Jun 05, 2026

European ADRs Slip As Nokia And Sequans Lead Declines - Finimize

Jun 05, 2026
pulisher
Jun 04, 2026

DBV Technologies Shareholders Approve Governance and Capital Measures - The Globe and Mail

Jun 04, 2026
pulisher
Jun 04, 2026

DBV's Moment of Truth: A Patch, a Promise, and a High-Stakes Pitch - BriefGlance

Jun 04, 2026
pulisher
Jun 03, 2026

DBV Technologies Announces the Results of its 2026 Combined General Meeting - markets.businessinsider.com

Jun 03, 2026
pulisher
Jun 02, 2026

DBV Technologies Announces First Participant Screened in THRIVE Phase 2 Study of the VIASKIN® Peanut Patch in Infants ages 6 through 12 Months with Peanut Allergy - The Manila Times

Jun 02, 2026
pulisher
Jun 02, 2026

DBV Technologies Announces First Participant Screened in - GlobeNewswire

Jun 02, 2026
pulisher
Jun 02, 2026

Peanut-allergic babies enter THRIVE study for skin patch therapy - Stock Titan

Jun 02, 2026
pulisher
Jun 02, 2026

European ADRs Tick Higher In US Trading - Finimize

Jun 02, 2026

Dbv Technologies Adr (DBVT) 財務データ

収益

loading

当期純利益

loading

現金流量

loading

EPS

loading

Dbv Technologies Adr (DBVT) インサイダートレーディング

インサイダートレーディング 関係 日付 取引 コスト #株式 値 ($) #株式総数
Mohideen Pharis
Chief Medical Officer
Jan 29 '26
Sale
4.86
534
2,595
144,995
EPIC Bpifrance
Member of 10% owner group
Dec 17 '25
Sale
4.85
2,076,990
10,070,232
8,595,472
EPIC Bpifrance
Member of 10% owner group
Dec 18 '25
Sale
4.19
1,292,103
5,413,912
7,303,369
Mohideen Pharis
Chief Medical Officer
Nov 20 '25
Sale
2.88
6,496
18,708
103,153
Mohideen Pharis
Chief Medical Officer
Nov 21 '25
Sale
2.77
1,624
4,498
101,529
$90.58
price down icon 2.44%
$119.52
price down icon 2.82%
$33.91
price down icon 1.77%
$58.43
price down icon 1.00%
$205.52
price up icon 0.02%
ONC ONC
$316.01
price down icon 1.88%
大文字化:     |  ボリューム (24 時間):